Advancing Commercialization Preparations to Expand Injectables Presence in China HONG KONG, Oct. 19...
Reinforcing Confidence in Long-Term Growth and Commitment to Shareholder Returns HONG KONG, Oct. 8,...
Injectables Business Fuels Rapid Growth as APAC Drives International Revenue Expansion HONG KONG, ...
Earnings Conference Call to be Held on August 20, 2026 HONG KONG, Aug. 5, 2026 /PRNewswire/ -- Sisr...
Harnessing dual-device synergies, multi-energy technologies, and pioneering layered protocols, Sisr...
Driving Innovation and Proactive Empowerment to Unlock Localized Growth in China HONG KONG, Aug. 4,...
Localization strategy advances with strengthened end-to-end capabilities across R&D, manufacturing ...
With advancing EBD rollout and steady injectables expansion, integrated treatment protocols deliver...
With advancing EBD rollout and steady injectables expansion, integrated treatment protocols deliver...
Advancing Global Medical Aesthetics Strategy and Unlocking Wellness Platform Value HONG KONG, May ...
Solid growth driven by strong performance in international markets, with the injectables business a...
Earnings Conference Call to be Held on March 24, 2026 HONG KONG, March 12, 2026 /PRNewswire/ -- Sis...
New clinical evidence highlights a smarter, technology-driven approach to scar management, rejuvena...
HONG KONG, Jan. 21, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; to...
Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfoli...
HONG KONG, Nov. 21, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; to...
HONG KONG, Oct. 28, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or " Sisram", 1696.HK; to...
HONG KONG, Sept. 4, 2025 /PRNewswire/ -- Sisram Medical (1696.HK), a global leading innovator and p...
HONG KONG, Aug. 20, 2025 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or " Sisram", 1696.HK; re...
H1 2025 conference call to be held on August 21, at 8:30 a.m. Eastern Time HONG KONG, Aug. 14, 2025...